IFITM1, CD10, SMA, and h-caldesmon as a helpful combination in differential diagnosis between endometrial stromal tumor and cellular leiomyoma

Table 3 Using receiver operating characteristic curves to evaluate the area-under-the-curve predictive value for prediction of endometrial stromal tumor and cellular leiomyoma

Groups for prediction of EST and CL	AUC
Combination of IFITM1 and CD10	0.930
Combination of IFITM1 and h-caldesmon	0.976
Combination of IFITM1and SMA	0.907
Combination of CD10 and h-caldesmon	0.952
Combination of CD10 and SMA	0.830
Combination of IFITM1, CD10, and h-caldesmon	0.984
Combination of IFITM1, CD10, and SMA	0.980
Combination of CD10, SMA, and h-caldesmon	0.956
Combination of IFITM1, CD10, SMA, and h-caldesmon	0.995

Abbreviations: AUC indicates Area-under-the-curve predictive value, EST indicates Endometrial Stromal Tumor, CL indicates Cellular leiomyoma

ISSN: 1471-2407